True Wealth Design LLC Makes New $30,000 Investment in Inspire Medical Systems, Inc. (NYSE:INSP)

True Wealth Design LLC bought a new stake in Inspire Medical Systems, Inc. (NYSE:INSP) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 141 shares of the company’s stock, valued at approximately $30,000.

Several other institutional investors and hedge funds have also modified their holdings of the business. Tidal Investments LLC bought a new stake in Inspire Medical Systems in the 1st quarter valued at about $1,151,000. CWM LLC boosted its stake in shares of Inspire Medical Systems by 101.6% in the second quarter. CWM LLC now owns 1,246 shares of the company’s stock valued at $167,000 after buying an additional 628 shares during the period. SG Americas Securities LLC grew its position in Inspire Medical Systems by 114.2% during the second quarter. SG Americas Securities LLC now owns 6,228 shares of the company’s stock worth $833,000 after buying an additional 3,321 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in Inspire Medical Systems by 118.5% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 3,079 shares of the company’s stock worth $412,000 after acquiring an additional 1,670 shares during the period. Finally, Neo Ivy Capital Management acquired a new position in Inspire Medical Systems in the 2nd quarter valued at $2,850,000. 94.91% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Shawn Mccormick sold 800 shares of the stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $220.00, for a total value of $176,000.00. Following the completion of the sale, the director now owns 23,140 shares of the company’s stock, valued at approximately $5,090,800. This represents a 3.34 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 4.10% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently commented on INSP shares. Truist Financial restated a “buy” rating and issued a $240.00 price target (up previously from $217.00) on shares of Inspire Medical Systems in a research report on Monday, September 30th. Royal Bank of Canada reissued an “outperform” rating and issued a $260.00 target price on shares of Inspire Medical Systems in a report on Tuesday, November 5th. KeyCorp decreased their price objective on shares of Inspire Medical Systems from $278.00 to $236.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 7th. Wells Fargo & Company boosted their price objective on shares of Inspire Medical Systems from $187.00 to $198.00 and gave the company an “equal weight” rating in a research report on Tuesday, November 5th. Finally, Robert W. Baird lifted their price target on Inspire Medical Systems from $240.00 to $252.00 and gave the company an “outperform” rating in a research note on Tuesday, November 5th. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Inspire Medical Systems currently has a consensus rating of “Moderate Buy” and a consensus price target of $233.58.

Inspire Medical Systems Stock Down 0.6 %

Shares of INSP opened at $192.76 on Monday. The stock has a market cap of $5.78 billion, a PE ratio of 180.15 and a beta of 1.36. Inspire Medical Systems, Inc. has a 12-month low of $123.00 and a 12-month high of $257.40. The business has a 50-day simple moving average of $197.96 and a two-hundred day simple moving average of $176.45.

Inspire Medical Systems (NYSE:INSP) last released its quarterly earnings data on Monday, November 4th. The company reported $0.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.06 by $0.54. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. The company had revenue of $203.20 million during the quarter, compared to the consensus estimate of $197.59 million. During the same quarter in the prior year, the firm posted ($0.29) earnings per share. The firm’s revenue was up 32.6% compared to the same quarter last year. On average, equities research analysts expect that Inspire Medical Systems, Inc. will post 1.33 EPS for the current year.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.